Corrigendum to"Efficacy of a combination of dutasteride,tadalafil,and solifenacin in the treatment of previously unsuccessful patients"[Asian J Urol 9(2022)42-50]  

作　　者：Kirill Kosilov Irina Kuzina Vladimir Kuznetsov Olga Barabash Ekaterina Fedorishcheva 

机构地区：[1]Department of Social Sciences,School of Humanities,Far Eastern Federal University,Vladivostok,Primorskyregion,Russian Federation [2]Department of Clinical Medicine,School of Medicine,Far Eastern Federal University,Vladivostok,Primorsky region,Russian Federation [3]Department of Public Health,Pacific State Medical University,Vladivostok,Primorsky region,Russian Federation [4]Department of Physical Culture and Health and Sports Work,Vladivostok State University of Economics and Service,Vladivostok,Primorsky region,Russian Federation

出　　处：《Asian Journal of Urology》2023年第1期117-118,共2页亚洲泌尿外科杂志（英文）

摘　　要：For the article entitled"Efficacy of a combination of dutasteride,tadalafil,and solifenacin in the treatment of previously unsuccessful patients"[Asian J Urol 9(2022)42-50,D0l:https://doi.org/10.1016/j.ajur.2021.04.002],the authors would like to correct some imprecise descriptions.The authors would like to sincerely apologize for these mistakes.

关 键 词：PATIENTS TREATMENT Cor 

分 类 号：R69-5[医药卫生—泌尿科学] G23[医药卫生—外科学]